Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed as a related resource, and the page revision has been updated from v3.5.3 to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-18T03:41:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s UI/version footer was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting an underlying change to the ClinicalTrials.gov site build rather than any content about the study.
    Difference
    0.0%
    Check dated 2026-04-26T15:48:06.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removed the Melanoma condition listing and the MedlinePlus Genetics related topics from the page.
    Difference
    0.1%
    Check dated 2026-04-12T11:24:55.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 and removed Padua, Italy, 35128 from the locations list.
    Difference
    0.0%
    Check dated 2026-04-05T07:19:28.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Napoli, Italy 80131 was updated to Naples, Italy 80131 and a Naples location was added. The page revision changed from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:08:50.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Melanoma is added to related topics, MedlinePlus Genetics is linked as a related topic, and a related article by Bautista et al. is cited. These are informational enhancements that do not modify core trial data or user actions on the page.
    Difference
    0.1%
    Check dated 2026-03-14T12:10:24.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.